12^th International Conference on Hypertension and Healthcare November 13-14, 2024 Dubai, UAE

Session 1: Hypertension
Hypertension is a chronic disease. It can be controlled with medication, but it cannot be cured. Due to the lack of noticeable symptoms, hypertension is a silent health condition. The only way of knowing the problem is to check your blood pressure. Hence the patients need to continue with the treatment and lifestyle modifications as advised by their doctor, and attend regular medical follow up, usually for life. To examine current patterns of hypertension (HTN) treatment, including blood pressure (BP) control, prevalence of different antihypertensive agents, and variations in treatment associated with patient and physician characteristics. Hypertension Conference is covering the topics such as Secondary Hypertension, Hypertension Rheumatoid Arthritis, Oncology and Blood Pressure, Genetic Factors of Hypertension, Life Style of High Blood Pressure.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 2: Pulmonary & Arterial hypertension
Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. The most relevant mechanisms for sudden cardiac death in PAH patients seem to be related to severe dilatation of the pulmonary artery, as subsequent complications, such as left main compression syndrome, pulmonary artery dissection, pulmonary artery rupture, and massive hemoptysis, may take place.An arterial high blood pressure has the characteristic of pressure indicators, either equal of higher than 140 mm Hg for the systolic or 90 mm Hg for the diastolic pressure, after having repeatedly measured the arterial tension. Essential arterial hypertension is one of the main treatable cardiovascular risk factors. It can be well controlled and the cardiovascular risk reduced through a combination of lifestyle interventions and first-line antihypertensive drugs.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 3: Pediatric Hypertension
In the pediatric population, hypertension is more commonly observed which is the major cause of mortality and morbidity in many countries.  And long-term health risk to children. It is also noted that there is a correlation between overweight obesity and hypertension and also blood pressure of parents and that of their offspring. Obese children have 3 fold risk of getting hypertension than that of no obese. Children with hypertension should also be screened for cardiovascular disease, including diabetes mellitus and hyperlipidaemia, and should be evaluated for target organ damage with a retinal examination and echocardiography.The ambulatory blood pressure (ABP) measures used to classify pediatric hypertension and left ventricular mass index (LVMI) in children with true ambulatory hypertension. Pediatric idiopathic intracranial hypertension is a rare condition, but inappropriate diagnosis and management may lead to devastating outcome with loss of vision and lifelong handicap.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 4: Resistance Hypertension
Resistance hypertension is high blood pressure that does not respond well to aggressive medical treatment. It is defined as failure to achieve goal blood pressures in patients taking optimal or maximum tolerated doses of three or more antihypertensive drugs, is estimated to occur in about 25% of hypertensive patients on treatment. Several factors have been identified as contributors to resistant hypertension. Poor patient adherence, physician inertia, inadequate doses or inappropriate combinations of antihypertensive drugs, excess alcohol intake, and volume overload are some of the most common causes of resistance.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 5: Renal/ Renovascular Hypertension
Renal /Renovascular hypertension caused by a narrowing of the arteries which convey blood to the kidney and which can be controlled by circulatory strain drugs. Individuals with renal hypertension can benefit from outside assistance by stenting, angioplasty, or surgery on the veins of the kidney. Renal hypertension mirrors the connection between blood vessel occlusive sickness and hoisted pulse. More particular determinations are made reflectively when hypertension enhances after intravascular intercession. Renal Hypertension Conference will give the subject are Signs and Side effects of Renal Hypertension, Pathogenesis of Renal Hypertension., Determination and Treatment, Hazard Variables for Renal Hypertension, Renal-supply route Angioplasty and Stenting. High circulatory strain is mostly unsafe as the patients by and large don't encounter the manifestations, so organ harm can happen gradually without being recognized. chronic kidney maladies can be caused by Renal Hypertension .Different strategies have been created to analyse renal hypertension utilizing computerized picture preparing of radiographs.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 6: Gestational Hypertension
Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.Gestational Hypertension Workshop related to the subjects are Classification of Pregnancy Induced Hypertension, Risk factors for Gestational Hypertension, Pre-eclampsia and Eclampsia, Pathogenesis of Pre-Eclampsia, Management of Hypertension in Pregnancy, Drug Treatment of Gestational Hypertension, Long Term Cardiovascular Sequelae of Gestational Hypertension.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 7: Heart & Cardiovascular diseases
All heart diseases are cardiovascular diseases, but not all cardiovascular diseases are heart disease. The most common type of heart disease is coronary heart disease. Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. The treatment for heart disease usually includes lifestyle changes.Heart conditions caused by high blood pressure known as Hypertensive heart disease. Heart problems associated with high blood pressure related to the heart arteries and muscles include narrowing of the arteries called Coronary Heart Disease (CHD) and Thickening and enlargement of the heart called Left Ventricular Hypertrophy (LVH). Both CHD and LVH can lead to heart failure, arrhythmia, ischemia, heart disease, heart attack, sudden cardiac arrest, stroke and sudden death.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 8: Hypertension Diagnosis and Assessment
Diagnostic trials usually include people who have signs or symptoms of the disease or condition being studied. It refers to trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.Hypertension is difficult to manage as the patients are generally symptomless and treatment is preventative rather than palliative. The best way to diagnose hypertension is to measure your blood pressure. If blood pressure is 140/90 mmHg or higher then offer ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension. Treatment of hypertension is important for the prevention of cardiovascular and kidney diseases.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 9: Hypertension Management
Randomized controlled trials have shown that managing hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. Despite the inherent health risks associated with uncontrolled hypertension, elevated blood pressure remains inadequately treated in the majority of patients.Treating high blood pressure includes diet changes, exercise, and medication. Changing lifestyle can lead to control high blood pressure.  The doctor may recommend for a healthy diet with less salt, regular exercise, quit smoking and maintain weight. But sometimes lifestyle changes aren't enough Some treatment and care for hypertension include High blood pressure drug supplement, calcium channel blockers ACE inhibitors, diuretics, beta blocker, omega-3 fish oil supplements etc.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 10: Prevalence and lifetime risk of hypertension
Hypertension is the major risk factor for cardiovascular disease stroke obesity. Lifetime risk estimates for disease condition are more easily understood by the general public compared with other measures of disease Hypertension is an important global health challenge due to its high prevalence and resulting cardiovascular disease and chronic kidney disease. The prevalence of hypertension is relatively very high. Hypertension Risk Factors Conference providing related topics are Controllable Risk Factors, Uncontrollable Risk Factors, Medical Risk Factors, Other Factors.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

Session 11: Coronary Intervention in HTN
Hypertension is associated with increased mortality in patients with ischemic heart disease after revascularization with percutaneous coronary intervention. Hypertension is associated with higher mortality in patients with STEMI, NSTEMI/UA or stable angina who are treated with PCI. The outcome in patients undergoing percutaneous coronary intervention in relation to diabetes and hypertension.People with high blood pressure are more likely to develop coronary artery disease, because high blood pressure puts added force against the artery walls. Over time, this extra pressure can damage the arteries, making them more vulnerable to the narrowing and plaque buildup associated with atherosclerosis.
Keywords: Hypertension Conferences | Healthcare Congress | Cardiology Meetings | Obesity Events | Pulmonary Workshops | Hypertension & Cardiology Conferences

The global hypertension drug market growth is driven through primary factors i.e. increase in sudden incidences of hypertension worldwide, people affected by diabetes, improvement in technology, and growing aging population. In addition, rising expenditures on health, an increase in cardiovascular diseases, and growing tobacco users are fuelling the growth of the global market. According to WHO (World Health Organization), more than 1.13 billion people are suffering from hypertension globally, among them, only 1 in each 5 is cured or under control.  WHO also states that in the 21st-century hypertension is one of the silent killers and one of the largest concerns of public health.
Data Bridge Market Research analyses that the hypertension market which was USD 31.76 billion in 2022, is expected to reach USD 43.18 billion by 2030, and is expected to undergo a CAGR of 4.00% during the forecast period of 2023 to 2030. “Hospitals” dominates the end user segment of the global hypertension market owing to the growing demand for drug. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Some of the major players operating in the global hypertension market are:

F. Hoffmann-La Roche Ltd (Switzerland)

Fresenius Kabi AG (Germany)

Bayer AG (Germany)

Sun Pharmaceutical Industries Ltd. (India)

Novartis AG (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd (Israel)

Zydus Group (India)

Pfizer Inc. (U.S.)

Lupin (India)

GSK Plc. (U.K.)

Glenmark Pharmaceuticals Inc. (India)

Wockhardt (India)

Attending a hypertension conference in 2024 can be highly beneficial for various professionals involved in the field of cardiovascular health. Here's a breakdown of who might consider attending

• Cardiologists
• Nephrologists
• Internal Medicine Physicians
•  Primary Care Physicians
• Researchers and Academics
• Medical Students and Trainees
• Industry Professionals
• Healthcare Administrators and Policy Makers
• Professors
• Doctors
• Students

Attending the Hypertension Conference in 2024 can offer numerous benefits for healthcare professionals, researchers, policymakers, and other stakeholders involved in hypertension management. Here are several compelling reasons to attend:

Stay Updated on Latest Research: Conferences provide a platform to learn about the latest developments and research findings in hypertension diagnosis, treatment, and prevention. By attending, you can gain insights into cutting-edge therapies, innovative technologies, and emerging trends in the field.

Networking Opportunities: Conferences bring together experts, practitioners, and industry professionals from around the world. It's an excellent opportunity to network, exchange ideas, and establish collaborations with peers who share similar interests or expertise in hypertension.

Professional Development: Participating in workshops, seminars, and panel discussions can enhance your knowledge and skills in hypertension management. You can acquire new techniques, strategies, and best practices to improve patient care and outcomes.

Access to Key Opinion Leaders: Conferences often feature keynote presentations and talks by renowned thought leaders and experts in hypertension research and clinical practice. Attending these sessions allows you to hear firsthand from leaders in the field and gain valuable insights from their experiences and expertise.

Exposure to New Products and Services: Conferences typically include exhibitions and vendor booths showcasing the latest pharmaceuticals, medical devices, and services related to hypertension management. It's an opportunity to explore new products, technologies, and resources that can benefit your practice or research.

Earn Continuing Education Credits: Many conferences offer continuing medical education (CME) credits or other professional development credits for attendees. By participating in educational sessions and workshops, you can fulfill your ongoing education requirements while staying abreast of advancements in hypertension care.

Contribute to the Field: If you're a researcher or clinician, presenting your work at a conference allows you to share your findings, insights, and experiences with a broader audience. It's a chance to receive feedback, engage in discussions, and contribute to the advancement of knowledge in hypertension.

Raise Awareness and Advocate: Conferences provide a platform to raise awareness about hypertension-related issues, advocate for policy changes, and promote public health initiatives aimed at preventing and managing hypertension. By participating, you can contribute to efforts to improve hypertension awareness, education, and access to care.

Overall, attending the Hypertension Conference in 2024 offers a unique opportunity to enhance your professional development, stay abreast of the latest research and trends, and connect with colleagues and experts in the field. It's a valuable investment in your career and a chance to make a positive impact on hypertension care and outcomes.

Participating in conferences can offer numerous benefits across various professional fields, including healthcare, academia, technology, business, and more. Here are some of the key benefits of attending conferences

Publishing the abstract in our respective Journals

Networking Opportunities.

Knowledge Sharing and Learning

Stay Updated on Industry Trends

Professional Development

Exposure to New Ideas and Perspectives

Promote Your Work or Business

Career Advancement Opportunities

Inspiration and Motivation

Best Poster & Young Researcher Award Nominations

Certification by the International Organizing Committee

Considering a visit to Dubai, UAE? Join us for our Meeting!

 Facing VISA complications?
To assist participants with their VISA application process, we provide VISA support documents, including:

•           Abstract acceptance letter (if speaker),

•           Registration payment receipt

 •          Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite. Mandate documents required Kindly contact

 Lisa Williams,
Program Manager